315 related articles for article (PubMed ID: 28120217)
1. Current treatment options of T cell-associated immunotherapy in multiple myeloma.
Liu H; Pan Y; Meng S; Zhang W; Zhou F
Clin Exp Med; 2017 Nov; 17(4):431-439. PubMed ID: 28120217
[TBL] [Abstract][Full Text] [Related]
2. Role of Immunotherapy in Targeting the Bone Marrow Microenvironment in Multiple Myeloma: An Evolving Therapeutic Strategy.
Chung C
Pharmacotherapy; 2017 Jan; 37(1):129-143. PubMed ID: 27870103
[TBL] [Abstract][Full Text] [Related]
3. Current Strategies for the Immunotherapy of Multiple Myeloma.
Luetkens T; Yousef S; Radhakrishnan SV; Atanackovic D
Oncology (Williston Park); 2017 Jan; 31(1):55-63. PubMed ID: 28090624
[TBL] [Abstract][Full Text] [Related]
4. [Research Progress of Bispecific Antibodies in Treatment of Multiple Myeloma--Review].
Han F; Zhang XP; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):952-956. PubMed ID: 38926994
[TBL] [Abstract][Full Text] [Related]
5. Immunopathogenesis and immunotherapy of multiple myeloma.
Tamura H
Int J Hematol; 2018 Mar; 107(3):278-285. PubMed ID: 29368256
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapeutic approaches to treat multiple myeloma.
Roeven MW; Hobo W; Schaap N; Dolstra H
Hum Vaccin Immunother; 2014; 10(4):896-910. PubMed ID: 24335570
[TBL] [Abstract][Full Text] [Related]
7. Current role of immunotherapy in multiple myeloma.
Hájek R; Adam Z; Krivanová A; Doubek M; Korístek Z; Vorlícek J
Acta Med Austriaca; 1998; 25(3):79-85. PubMed ID: 9816399
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for multiple myeloma: Current status and future directions.
Ayed AO; Chang LJ; Moreb JS
Crit Rev Oncol Hematol; 2015 Dec; 96(3):399-412. PubMed ID: 26153389
[TBL] [Abstract][Full Text] [Related]
9. Immune therapy in multiple myeloma.
Luptakova K; Avigan D
Clin Adv Hematol Oncol; 2015 Nov; 13(11):767-75. PubMed ID: 27058703
[TBL] [Abstract][Full Text] [Related]
10. New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.
Neri P; Bahlis NJ; Lonial S
Clin Cancer Res; 2016 Dec; 22(24):5959-5965. PubMed ID: 27797968
[TBL] [Abstract][Full Text] [Related]
11. The immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies.
Hoyos V; Borrello I
Blood; 2016 Sep; 128(13):1679-87. PubMed ID: 27506540
[TBL] [Abstract][Full Text] [Related]
12. An anti-B cell maturation antigen bispecific antibody for multiple myeloma.
Ramadoss NS; Schulman AD; Choi SH; Rodgers DT; Kazane SA; Kim CH; Lawson BR; Young TS
J Am Chem Soc; 2015 Apr; 137(16):5288-91. PubMed ID: 25826669
[TBL] [Abstract][Full Text] [Related]
13. Advances in immunotherapy in multiple myeloma.
Boussi L; Niesvizky R
Curr Opin Oncol; 2017 Nov; 29(6):460-466. PubMed ID: 28877078
[TBL] [Abstract][Full Text] [Related]
14. Seeking Convergence and Cure with New Myeloma Therapies.
Choudhry P; Galligan D; Wiita AP
Trends Cancer; 2018 Aug; 4(8):567-582. PubMed ID: 30064664
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy strategies in multiple myeloma.
Bae J; Munshi NC; Anderson KC
Hematol Oncol Clin North Am; 2014 Oct; 28(5):927-43. PubMed ID: 25212890
[TBL] [Abstract][Full Text] [Related]
16. Immunology and immunotherapeutic approaches in multiple myeloma.
Schlude C; Beckhove P
Recent Results Cancer Res; 2011; 183():97-109. PubMed ID: 21509682
[TBL] [Abstract][Full Text] [Related]
17. Immunodeficiency and immunotherapy in multiple myeloma.
Pratt G; Goodyear O; Moss P
Br J Haematol; 2007 Sep; 138(5):563-79. PubMed ID: 17686051
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cell immunotherapy against multiple myeloma: Progress and possibilities.
Liu P; Jin Y; Sattar H; Liu H; Xie W; Zhou F
J Leukoc Biol; 2018 May; 103(5):821-828. PubMed ID: 29733502
[TBL] [Abstract][Full Text] [Related]
19. Current management and emerging treatment strategies for multiple myeloma.
Lei M; Kim EB; Branagan A; Lou U; Zemel M; Raje N
Rinsho Ketsueki; 2019; 60(9):1243-1256. PubMed ID: 31597850
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function?
Venken K; Favreau M; Gaublomme D; Menu E; Vanderkerken K; Elewaut D
Mol Immunol; 2018 Sep; 101():521-526. PubMed ID: 30153633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
